Monoclonal Antibody News and Research

RSS
Monoclonal antibodies (MAbs) are produced from a single B cell clone and can bind to a single type of antigen binding site. MAbs are homogenous antibodies that cannot form lattices with monomeric proteins as they can bind to only a single epitope on the antigen. Developed in the 1970s, MAbs can be produced against any given substance. Thus they can be used to detect and purify any substance of interest. This has made MAbs a powerful tool of molecular biology, biochemistry, and medicine.
Drug-resistant SARS-CoV-2 variants found in immunocompromised patients

Drug-resistant SARS-CoV-2 variants found in immunocompromised patients

Early intervention in pediatric-onset MS can lead to improved long-term outcomes

Early intervention in pediatric-onset MS can lead to improved long-term outcomes

Researchers discover how oral cancer cells may block the body's immune response

Researchers discover how oral cancer cells may block the body's immune response

Monoclonal antibodies could help provide an answer to antimicrobial resistance

Monoclonal antibodies could help provide an answer to antimicrobial resistance

Review highlights mitochondrial dysfunction in cholestatic liver injury

Review highlights mitochondrial dysfunction in cholestatic liver injury

New research network focuses on high-priority viruses

New research network focuses on high-priority viruses

AI-powered treatment allocation improves public health outcomes

AI-powered treatment allocation improves public health outcomes

Current and emerging biomarkers in the management of inflammatory bowel disease

Current and emerging biomarkers in the management of inflammatory bowel disease

Study links protein increases to cognitive improvement in Alzheimer's

Study links protein increases to cognitive improvement in Alzheimer's

Novel monoclonal antibody appears effective at neutralizing numerous SARS-CoV-2 variants

Novel monoclonal antibody appears effective at neutralizing numerous SARS-CoV-2 variants

Fibrin fuels thromboinflammation and brain damage in COVID-19

Fibrin fuels thromboinflammation and brain damage in COVID-19

Study reveals the role of blood clotting in COVID-19

Study reveals the role of blood clotting in COVID-19

New trial explores BAFF CAR T-cell therapy for relapsed myeloma

New trial explores BAFF CAR T-cell therapy for relapsed myeloma

Exploring alemtuzumab in reduced-toxicity conditioning for Asian patients with inborn errors of immunity

Exploring alemtuzumab in reduced-toxicity conditioning for Asian patients with inborn errors of immunity

Breakthrough research identifies fibrin as key factor in preterm brain bleeds

Breakthrough research identifies fibrin as key factor in preterm brain bleeds

Researchers identify ORF6 protein as key to SARS-CoV-2 immune evasion

Researchers identify ORF6 protein as key to SARS-CoV-2 immune evasion

Almirall's Ebglyss recommended by NICE for NHS atopic dermatitis patients

Almirall's Ebglyss recommended by NICE for NHS atopic dermatitis patients

Clinical trial seeks to evaluate safety of new EV-D68 treatment

Clinical trial seeks to evaluate safety of new EV-D68 treatment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.